LADENBURG THALMANN FINANCIAL SERVICES INC. - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$3,0000.0%1,100
+10.0%
0.00%
Q3 2019$3,000
-25.0%
1,000
-33.3%
0.00%
Q2 2019$4,000
-33.3%
1,5000.0%0.00%
Q1 2019$6,000
+20.0%
1,5000.0%0.00%
Q4 2018$5,000
-44.4%
1,5000.0%0.00%
Q3 2018$9,000
+80.0%
1,500
+50.0%
0.00%
Q2 2018$5,0000.0%1,0000.0%0.00%
Q1 2018$5,000
-16.7%
1,0000.0%0.00%
Q4 2017$6,000
-95.1%
1,000
-95.5%
0.00%
-100.0%
Q3 2017$122,000
+14.0%
22,000
-4.3%
0.00%0.0%
Q2 2017$107,000
+2040.0%
23,000
+2200.0%
0.00%
Q1 2017$5,000
-54.5%
1,0000.0%0.00%
Q4 2016$11,000
+22.2%
1,0000.0%0.00%
Q3 2016$9,000
+50.0%
1,0000.0%0.00%
Q2 2016$6,000
-14.3%
1,0000.0%0.00%
Q1 2016$7,000
-12.5%
1,0000.0%0.00%
Q4 2015$8,000
-27.3%
1,000
-33.3%
0.00%
Q3 2015$11,000
+37.5%
1,500
+100.0%
0.00%
Q2 2015$8,000
+60.0%
750
+50.0%
0.00%
Q1 2015$5,000
+25.0%
5000.0%0.00%
Q4 2014$4,0005000.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q1 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$28,738,0004.90%
DSC Advisors, L.P. 1,187,604$7,138,0004.14%
Opaleye Management Inc. 960,000$5,769,0001.85%
DAFNA Capital Management LLC 352,741$2,120,0001.14%
Vivo Capital, LLC 855,000$5,139,0001.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 382,838$2,301,0000.81%
SENZAR ASSET MANAGEMENT, LLC 377,397$2,268,0000.58%
Sio Capital Management, LLC 131,200$789,0000.44%
Perceptive Advisors 1,117,324$6,715,0000.22%
Tekla Capital Management LLC 930,398$5,592,0000.22%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders